Skip to main content
. Author manuscript; available in PMC: 2017 Jan 6.
Published in final edited form as: Leukemia. 2016 Jun 14;31(1):170–176. doi: 10.1038/leu.2016.172

Figure 2. Time to Treatment and presence of mutations.

Figure 2

A) Comparison of TTT in cases with mutations in any of the 21 genes versus cases without mutations. B) Comparison of TTT between cases with mutations in BIRC3, NOTCH1 or SF3B1 vs. other mutations vs. no mutations.